Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 28, 2022

TET2-Driven Clonal Hematopoiesis and Response to Canakinumab

JAMA Cardiology


Additional Info

JAMA Cardiology
TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial
JAMA Cardiol 2022 Apr 06;[EPub Ahead of Print], EC Svensson, A Madar, CD Campbell, Y He, M Sultan, ML Healey, H Xu, K D'Aco, A Fernandez, C Wache-Mainier, P Libby, PM Ridker, MT Beste, CT Basson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading